Impact of surgical versus endoscopic management of complex nonmalignant polyps in a colorectal cancer screening program

Abstract

Background When complex nonmalignant polyps are detected in colorectal cancer (CRC) screening programs, patients may be referred directly to surgery or may first undergo additional endoscopy for attempted endoscopic removal by an expert. We compared the impact of both strategies on screening effectiveness and costs.

Methods We used MISCAN-Colon to simulate the Dutch screening program, and projected CRC deaths prevented, quality-adjusted life-years (QALYs) gained, and costs for two scenarios: 1) surgery for all complex nonmalignant polyps; 2) attempted removal by an expert endoscopist first. We made the following assumptions: 3.9 % of screen-detected large nonmalignant polyps were complex; associated surgery mortality was 0.7 %; the rate of successful removal by an expert was 87 %, with 0.11 % mortality.

Results The screening program was estimated to prevent 11.2 CRC cases (–16.7 %) and 10.1 CRC deaths (–27.1 %), resulting in 32.9 QALYs gained (+ 17.2 %) per 1000 simulated individuals over their lifetimes compared with no screening. The program would also result in 2.1 surgeries for complex nonmalignant polyps with 0.015 associated deaths per 1000 individuals. If, instead, these patients were referred to an expert endoscopist first, only 0.2 patients required surgery, reducing associated deaths by 0.013 at the expense of 0.003 extra colonoscopy deaths. Compared with direct referral to surgery, referral to an expert endoscopist gained 0.2 QALYs and saved €12 500 per 1000 individuals in the target population.

Conclusion Referring patients with complex polyps to an expert endoscopist first reduced some surgery-related deaths while substantially improving cost-effectiveness of the screening program.

Publication History

Received: 04 May 2021

Accepted: 29 November 2021

Article published online:
07 February 2022

• References

• 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249
• 2 Lin JS, Perdue LA, Henrikson NB. et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021; 325: 1978-1998
• 3 Schreuders EH, Ruco A, Rabeneck L. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64: 1637-1649
• 4 Friedland S, Banerjee S, Kochar R. et al. Outcomes of repeat colonoscopy in patients with polyps referred for surgery without biopsy-proven cancer. Gastrointest Endosc 2014; 79: 101-107
• 5 Peery AF, Shaheen NJ, Cools KS. et al. Morbidity and mortality after surgery for nonmalignant colorectal polyps. Gastrointest Endosc 2018; 87: 243-250
• 6 Moon N, Aryan M, Khan W. et al. Effect of referral pattern and histopathology grade on surgery for nonmalignant colorectal polyps. Gastrointest Endosc 2020; 92: 702-711
• 7 Grimm I, Peery AF, Kaltenbach T. et al. Quality matters: improving the quality of care for patients with complex colorectal polyps. Am J Gastroenterol 2018; 113: 317-321
• 8 Tate DJ, Sidhu M, Bar-Yishay I. et al. Impact of en bloc resection on long-term outcomes after endoscopic mucosal resection: a matched cohort study. Gastrointest Endosc 2020; 91: 1155-1163
• 9 de Neree Tot Babberich MPM, Bronzwaer MES, Andriessen JO. et al. Outcomes of surgical resections for benign colon polyps: a systematic review. Endoscopy 2019; 51: 961-972
• 10 Tate DJ, Desomer L, Heitman SJ. et al. Clinical implications of decision making in colorectal polypectomy: an international survey of Western endoscopists suggests priorities for change. Endosc Int Open 2020; 8: E445-E455
• 11 Rex DK. If endoscopic mucosal resection is so great for large benign colon polyps, why is so much surgery still being done?. Endoscopy 2018; 50: 657-659
• 12 Pioche M, Cotte E, Hassan C. Overutilization of surgery for the resection of benign colorectal lesions: the hidden reasons for inappropriate referral!. Endosc Int Open 2021; 9: E713-E715
• 13 Saade R, Tsang T, Kmeid M. et al. Overutilization of surgical resection for benign colorectal polyps: analysis from a tertiary care center. Endosc Int Open 2021; 9: E706-E712
• 14 Bronzwaer MES, Koens L, Bemelman WA. et al. Volume of surgery for benign colorectal polyps in the last 11 years. Gastrointest Endosc 2018; 87: 552-561
• 15 Jayanna M, Burgess NG, Singh R. et al. Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions. Clin Gastroenterol Hepatol 2016; 14: 271-278
• 16 Law R, Das A, Gregory D. et al. Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis. Gastrointest Endosc 2016; 83: 1248-1257
• 17 Keswani RN, Law R, Ciolino JD. et al. Adverse events after surgery for nonmalignant colon polyps are common and associated with increased length of stay and costs. Gastrointest Endosc 2016; 84: 296-303
• 18 Gamaleldin M, Benlice C, Delaney CP. et al. Management of the colorectal polyp referred for resection: a case-matched comparison of advanced endoscopic surgery and laparoscopic colectomy. Surgery 2018; 163: 522-527
• 19 Ahlenstiel G, Hourigan LF, Brown G. et al. Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon. Gastrointest Endosc 2014; 80: 668-676
• 20 Dahan M, Pauliat E, Liva-Yonnet S. et al. What is the cost of endoscopic submucosal dissection (ESD)? A medico-economic study. United European Gastroenterol J 2019; 7: 138-145
• 21 Van Hees F, Zauber AG, Van Veldhuizen H. et al. The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands. Gut 2015; 64: 1985-1997
• 22 European Commission. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1. Luxembourg: Publications Office of the European Union; 2010
• 23 Toes-Zoutendijk E, van Leerdam ME, Dekker E. et al. Real-time monitoring of results during first year of Dutch Colorectal Cancer Screening Program and optimization by altering fecal immunochemical test cut-off levels. Gastroenterology 2017; 152: 767-775
• 24 National Institute for Public Health and the Environment. Ministry of Health, Welfare and Sport. Monitoring and Evaluation of the Colorectal Cancer Screening Programme 2014. http://www.rivm.nl/en/Documents_and_publications/Common_and_Present/Publications/Disease_prevention_and_healthcare/bowel_cancer/National_Monitoring_of_the_Colorectal_Cancer_Screening_Programme Accessed: 1 July 2021
• 25 Dekker E, van Leerdam ME, Hazewinkel Y. et al. Nederlandse Richtlijn Coloscopie Surveillance. In: Dutch Guidelines on Coloscopy Surveillance. https://www.mdl.nl/files/richlijnen/Richtlijn_Coloscopie_Surveillance_definitief_2013.pdf Accessed: 1 July 2021
• 26 Hol L, Wilschut JA, van Ballegooijen M. et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009; 100: 1103-1110
• 27 Hassan C, Repici A, Sharma P. et al. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut 2016; 65: 806-820
• 28 Gatto NM, Frucht H, Sundararajan V. et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003; 95: 230-236
• 29 Dutch Institute for Clinical Auditing. https://www.dica.nl/dsca Accessed: 1 July 2021
• 30 Le Roy F, Manfredi S, Hamonic S. et al. Frequency of and risk factors for the surgical resection of nonmalignant colorectal polyps: a population-based study. Endoscopy 2016; 48: 263-270
• 31 Kaltenbach T, Soetikno R. Endoscopic resection of large colon polyps. Gastrointest Endosc Clin N Am 2013; 23: 137-152
• 32 Kapidzic A, Grobbee EJ, Hol L. et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 2014; 109: 1257-1264